In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brendan Frey, founder and chief innovation officer of ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

AstraZeneca's Fasenra has been cleared for use by the NHS in England as an add-on treatment for the rare autoimmune disease ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Vedanta is playing catch-up with VE303, however, as a rival microbiome therapy from Seres Therapeutics, called Vowst, has ...

Following the first-ever FDA approval of a TIL therapy in the U.S., and with regulatory decisions pending in Canada and ...

Returning for its third year, the Donor Selection & Cell Source Summit is the only industry-dedicated forum focused ...

Improved patient outcomes and safety: Ultimately, smarter learning powered by AI should lead to better care. More ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...